Skip to main content

Advertisement

Log in

Integrating Screening, Brief Intervention and Referral to Treatment (SBIRT) for Substance Use into Prenatal Care

  • From the Field
  • Published:
Maternal and Child Health Journal Aims and scope Submit manuscript

Abstract

Objectives

Universal screening for substance use during pregnancy, brief intervention, and referral to treatment (SBIRT) is recommended by ACOG and the USPSTF. Here we present the implementation of SBIRT into the electronic health record (EHR) to inform clinical intervention and collect data on the prevalence of substance use during pregnancy at three prenatal clinics.

Methods

A literature-based SBIRT instrument was developed. The tool was integrated into the EHR of a resident Ob/Gyn clinic, an MFM practice, and an Ob/Gyn generalist practice at our institution, an academic, tertiary care medical center in an urban area, and automated reports of aggregate retrospective EHR data were used to monitor patient responses to SBIRT over time. Data reports included patient responses to screening for substance use, brief intervention, and referral to treatment from January to December 2018

Results

An interprofessional team of health care providers and systems analysts guided the SBIRT implementation process. As of December 2018, overall SBIRT performance during prenatal care encounters was 1797/2619 (69%), 432/1350 (32%), and 1290/1518 (85%) in the resident clinic, MFM practice, and generalist practice, respectively. Eighty (5.1%) women in the resident clinic, 2 (0.5%) in the MFM practice and 14 (1%) in the generalist practice reported past or present substance use.

Conclusions for Practice

Integrating universal SBIRT into prenatal care using the EHR requires a multi-disciplinary approach. The SBIRT tool facilitates reportable substance use screening, brief intervention, and referral to treatment during prenatal care. Future reports will further characterize substance use in our prenatal practices and inform intervention strategies in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  • ACOG. (2017). Committee opinion no. 711: Opioid use and opioid use disorder in pregnancy. Obstetrics & Gynecology,130(2), e81–e94.

    Article  Google Scholar 

  • Center for Adolescent Substance Abuse Research. (2009) Children’s Hospital Boston. The CRAFFT screening interview. Boston (MA): CeSAR. Retrieved April 30, 2019 from https://www.ceasar.org/CRAFFT/pdf/CRAFFT_English.pdf

  • Chasnoff, I. J., Landress, H. J., & Barrett, M. E. (1990). The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. The New England Journal of Medicine,322(17), 1202–1206.

    Article  CAS  Google Scholar 

  • Ewing, H. (1990). A practical guide to intervention in health and social services with pregnant and postpartum addicts and alcohol- ics: Theoretical framework, brief screening tool, key interview questions, and strategies for referral to recovery resources. Martinez (CA): The Born Free Project, Contra Costa County Department of Health Services.

    Google Scholar 

  • Guttmann, A., Blackburn, R., Amartey, A., Zhou, L., Wijlaars, L., Saunders, N., et al. (2019). Longterm mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel cohort study in England and Ontario Canada. PLoS Medicine,16(11), e1002974. https://doi.org/10.1371/journal.pmed.1002974.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hser, Y. I., Kagihara, J., Huang, D., Evans, E., & Messina, N. (2012). Mortality among substance-using mothers in California: A 10-year prospective study. Addiction,107(1), 215. https://doi.org/10.1111/j.1360-0443.2011.03613.x.

    Article  PubMed  Google Scholar 

  • Jonas, D. E., Garbutt, J. C., Amick, H. R., Brown, J. M., Brownley, K. A., Council, C. L., et al. (2012). Behavioral counseling after screening for alcohol misuse in primary care: A systematic review and meta-analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine,157(9), 645–654.

    Article  Google Scholar 

  • Kahila, H., Gissler, M., Sarkola, T., Autti-Ramo, I., & Halmesmaki, E. (2010). Maternal welfare, morbidity and mortality 6–15 years after a pregnancy complicated bxfy alcohol and substance abuse: a register-based case-control follow-up study of 524 women. Drug and Alcohol Dependence.,111(3), 215. https://doi.org/10.1016/j.drugalcdep.2010.04.014.

    Article  PubMed  Google Scholar 

  • National Institute on Drug Abuse. Resource guide: screening for drug use in general medical settings. Retrieved May 22, 2019 from https://www.drugabuse.gov/publications/resource-guide-screening-drug-use-in-general-medical-settings/nida-quick-screen

  • Osterman, M. J. K., & Martin, J. A. (2018). Timing and adequacy of prenatal care in the United States, 2016. National Vital Statistics Reports 67. Hyattsville, MD: National Center for Health Statistics.

    Google Scholar 

  • Patrick, S. W., Davis, M. M., Lehmann, C. U., & Cooper, W. O. (2015). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology,35(8), 650–655.

    Article  CAS  Google Scholar 

  • SAMHSA (2017). The National survey on drug use and health: 2017. Rockville (MD): Substance abuse and mental health services administration. Retrieved January 2, 2020 from https://www.samhsa.gov/data/sites/default/files/nsduh-ppt-09-2018.pdf.

  • Taylor, M. J., McNicholas, C., Nicolay, C., Darzi, A., Bell, D., & Reed, J. E. (2014). Systematic review of the application of the plan-do-study-act method to improve quality in healthcare. BMJ Quality & Safety,23(4), 290–298. https://doi.org/10.1136/bmjqs-2013-001862.

    Article  Google Scholar 

  • USPSTF. (2009). Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Annals of Internal Medicine, 150(8), 551–555. Retrieved May 21, 2019 from https://www.ncbi.nlm.nih.gov/pubmed/19380855

  • Viteri, O. A., Soto, E. E., Bahado-Singh, R. O., Christensen, C. W., Chauhan, S. P., & Sibai, B. M. (2015). Fetal anomalies and long-term effects associated with substance abuse in pregnancy: A literature review. The American Journal of Perinatology,32(5), 405–416.

    PubMed  Google Scholar 

  • Wright, T. E., Terplan, M., Ondersma, S. J., Boyce, C., Yonkers, K., Chang, G., et al. (2016). The role of screening, brief intervention, and referral to treatment in the perinatal period. American Journal of Obstetrics and Gynecology,215(5), 539–547.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean C. Hostage.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hostage, J.C., Brock, J., Craig, W. et al. Integrating Screening, Brief Intervention and Referral to Treatment (SBIRT) for Substance Use into Prenatal Care. Matern Child Health J 24, 412–418 (2020). https://doi.org/10.1007/s10995-020-02892-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10995-020-02892-9

Keywords

Navigation